JPS5951537B2 - 新規α−アミノオキシカルボン酸ヒドラジド誘導体の製造法 - Google Patents

新規α−アミノオキシカルボン酸ヒドラジド誘導体の製造法

Info

Publication number
JPS5951537B2
JPS5951537B2 JP49136382A JP13638274A JPS5951537B2 JP S5951537 B2 JPS5951537 B2 JP S5951537B2 JP 49136382 A JP49136382 A JP 49136382A JP 13638274 A JP13638274 A JP 13638274A JP S5951537 B2 JPS5951537 B2 JP S5951537B2
Authority
JP
Japan
Prior art keywords
formula
group
acid
acid addition
nitrofuryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP49136382A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5084523A (fr
Inventor
キスフアルデイ ラヨス
ダンシ ラヨス
パテイ ネ− ルカツ アグネス
フエケテ ジヨルジイ
スザボ イストバン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIHITAA GEDEON BEGIESUZECHI GIARU AARU TEII
Original Assignee
RIHITAA GEDEON BEGIESUZECHI GIARU AARU TEII
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIHITAA GEDEON BEGIESUZECHI GIARU AARU TEII filed Critical RIHITAA GEDEON BEGIESUZECHI GIARU AARU TEII
Publication of JPS5084523A publication Critical patent/JPS5084523A/ja
Publication of JPS5951537B2 publication Critical patent/JPS5951537B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5
    • C07D307/72—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
    • C07D307/73—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by amino or imino, or substituted amino or imino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
JP49136382A 1973-11-29 1974-11-29 新規α−アミノオキシカルボン酸ヒドラジド誘導体の製造法 Expired JPS5951537B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU000530 1973-11-29
HURI530A HU167365B (fr) 1973-11-29 1973-11-29

Publications (2)

Publication Number Publication Date
JPS5084523A JPS5084523A (fr) 1975-07-08
JPS5951537B2 true JPS5951537B2 (ja) 1984-12-14

Family

ID=11000941

Family Applications (2)

Application Number Title Priority Date Filing Date
JP49136382A Expired JPS5951537B2 (ja) 1973-11-29 1974-11-29 新規α−アミノオキシカルボン酸ヒドラジド誘導体の製造法
JP57052368A Expired JPS5953264B2 (ja) 1973-11-29 1982-04-01 新規α−アミノオキシカルボン酸ヒドラジド誘導体の製造法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP57052368A Expired JPS5953264B2 (ja) 1973-11-29 1982-04-01 新規α−アミノオキシカルボン酸ヒドラジド誘導体の製造法

Country Status (13)

Country Link
JP (2) JPS5951537B2 (fr)
AT (1) AT340920B (fr)
BE (1) BE822767A (fr)
CA (1) CA1018171A (fr)
CH (2) CH614954A5 (fr)
CS (1) CS199568B2 (fr)
DD (1) DD118874A5 (fr)
DE (1) DE2455353C3 (fr)
FR (1) FR2252845B1 (fr)
GB (1) GB1446980A (fr)
HU (1) HU167365B (fr)
NL (1) NL7415589A (fr)
SU (2) SU574146A3 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE52765T1 (de) * 1984-10-18 1990-06-15 Shell Int Research Alpha-aminooxy-c4-alkansaeuren und -ester.
US5002605A (en) * 1988-12-21 1991-03-26 Ici Americas Inc. Alkylidine aminooxyamide compounds useful in controlling undesirable vegetation
EA011074B1 (ru) 2004-03-30 2008-12-30 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Гидразидсодержащие соединения - ингибиторы cftr и их применение
WO2008079897A2 (fr) 2006-12-22 2008-07-03 The Regents Of The University Of California Conjugués macromoléculaires d'inhibiteurs de la protéine régulatrice de la perméabilité transmembranaire de la fibrose kystique
US8283351B2 (en) 2007-04-02 2012-10-09 Institute For Oneworld Health Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof
ES2422603T3 (es) 2007-05-31 2013-09-12 Shionogi & Co Compuestos oxiimino y el uso de estos
WO2008150447A1 (fr) * 2007-05-31 2008-12-11 Euro-Celtique S.A. Composés d'amide et leur utilisation
WO2009131957A2 (fr) 2008-04-21 2009-10-29 Institute For Oneworld Health Composés, compositions et traitements comprenant des dérivés d'oxydiazoles
US8236838B2 (en) 2008-04-21 2012-08-07 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
WO2009151152A1 (fr) 2008-06-11 2009-12-17 Shionogi & Co., Ltd. Composés oxycarbamoyle et leur utilisation
US8343976B2 (en) 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
CN102276593B (zh) * 2011-07-01 2013-10-30 华东师范大学 杂环烯酮腙化合物和制备方法及抗结核菌的应用
WO2014201446A2 (fr) 2013-06-14 2014-12-18 Hellmich Mark Utilisation d'inhibiteurs de synthèse de sulfure d'hydrogène pour le traitement des cancers du rectum et du côlon

Also Published As

Publication number Publication date
DE2455353B2 (de) 1978-12-07
CA1018171A (fr) 1977-09-27
SU574146A3 (ru) 1977-09-25
CH614954A5 (en) 1979-12-28
CH612926A5 (en) 1979-08-31
DE2455353A1 (de) 1975-06-05
NL7415589A (nl) 1975-06-02
FR2252845A1 (fr) 1975-06-27
ATA940574A (de) 1977-05-15
BE822767A (fr) 1975-03-14
AT340920B (de) 1978-01-10
JPS57192365A (en) 1982-11-26
GB1446980A (en) 1976-08-18
JPS5084523A (fr) 1975-07-08
CS199568B2 (en) 1980-07-31
FR2252845B1 (fr) 1978-07-21
SU608472A3 (ru) 1978-05-25
DE2455353C3 (de) 1979-08-09
HU167365B (fr) 1975-09-27
JPS5953264B2 (ja) 1984-12-24
DD118874A5 (fr) 1976-03-20

Similar Documents

Publication Publication Date Title
US12043617B2 (en) 4-(N-methyl) aminopiperidine myricetin derivative containing dithiocarbamate, preparation method and application
DE69715010T2 (de) Ausgewählte k-252a derivate
BG62090B1 (bg) Заместени бензамидини, тяхното получаване и използването имкато лекарствени средства
CA3012846A1 (fr) Liants de max comme modulateurs de myc et leurs utilisations
EP3611170B1 (fr) Composés par deutération et applications médicales en tant qu'agents anxiolytiques
US4656192A (en) Tropolone derivatives, processes for the preparation thereof and the use thereof as anti-tumor agents
CN112521371B (zh) 杂环酰胺类化合物、其可药用的盐及其制备方法和用途
CN107200734B (zh) 奎宁环衍生物及其制备方法和用途
JPS5953264B2 (ja) 新規α−アミノオキシカルボン酸ヒドラジド誘導体の製造法
BR112013007073A2 (pt) derivados do cromeno; composição farmacêutica; utilização de um composto da fórmula i e processo de preparação de um composto da fórmula i
CN109516926B (zh) 一种荜茇明碱衍生物制备及用途
FR2758329A1 (fr) Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique
CN116874465B (zh) 嘧啶类化合物及其应用
WO2024234619A1 (fr) Forme cristalline d'un composé, composition pharmaceutique et utilisation de celles-ci
JPS62281860A (ja) アルキレンアミノアルキレン　ヘテロ原子基を有するジヒドロ−３，５−ジカルボキシレ−ト
RU2075477C1 (ru) 1-//2-(динизший алкиламино)алкил/амино/-4-замещенные тиоксантен-9-оны и фармацевтическая композиция, обладающая противоопухолевой активностью
CA1058195A (fr) L'AMIDE .alpha.-AMINOOXYCARBOXYLIQUE ET PROCEDE POUR LEUR PREPARATION
JPH0322394B2 (fr)
JPS6183163A (ja) 抗腫瘍剤
CN112940009A (zh) 一种磺酸多环化合物及其药物组合物和用途
CA1043800A (fr) Derives d'acide hydroxamique d'acides l-aminocarboxyliques substitues
JPS6383088A (ja) ベンゾピラノピラゾレン誘導体
JPH0789920A (ja) 新規な化合物
EP0343832A2 (fr) Composés de 5H-pyrazolo(4,3-a)quinolizin-5-one aux activités thérapeutiques
CA2117131A1 (fr) Derives aminoquinoline